Kforce (NASDAQ:KFRC) will release its quarterly earnings report on Monday, 2026-02-02. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Kforce to report an earnings per share (EPS) of $0.47.
The announcement from Kforce is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
The company's EPS beat by $0.06 in the last quarter, leading to a 28.69% increase in the share price on the following day.
Here's a look at Kforce's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.57 | 0.60 | 0.47 | 0.6 |
| EPS Actual | 0.63 | 0.59 | 0.45 | 0.6 |
| Price Change % | 29.00 | -18.00 | -14.00 | 1.0 |
Stock Performance
Shares of Kforce were trading at $32.93 as of January 29. Over the last 52-week period, shares are down 35.91%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Insights Shared by Analysts on Kforce
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Kforce.
Analysts have provided Kforce with 2 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $36.25, suggesting a potential 10.08% upside.
Analyzing Analyst Ratings Among Peers
This comparison focuses on the analyst ratings and average 1-year price targets of Alight, Kelly Services and Barrett Business Services, three major players in the industry, shedding light on their relative performance expectations and market positioning.
Key Findings: Peer Analysis Summary
In the peer analysis summary, key metrics for Alight, Kelly Services and Barrett Business Services are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.
Key Takeaway:
Kforce ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. Kforce is at the top for Return on Equity.
Unveiling the Story Behind Kforce
Kforce: A Financial Overview
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Kforce's financials over 3 months reveals challenges. As of 30 September, 2025, the company experienced a decline of approximately -5.85% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Kforce's net margin is impressive, surpassing industry averages. With a net margin of 3.33%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Kforce's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.3% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Kforce's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.96% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Kforce's debt-to-equity ratio is below the industry average. With a ratio of 0.61, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
To track all earnings releases for Kforce visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

